PS

Pierre Socha

Partner at Amadeus Capital

Cambridge, England

Overview

Work Experience

  • Partner

    2012 - Current

    - Investing in industry defining technologies size 1997 - Healthtech, Human-Computer Interfaces, Quantum, Material Science, Autonomous Systems, Cybersecurity - Backing entrepreneurs from 5th generation funds; Over $1bn under management, >200 investments.

  • Board Member

    2022

    Synthetic reprogramming platform, to make new materials from drugs to electronics

  • Board Member

    2020

    V7 is turning the computer-vision workflow into the AI product, giving machines human-like visual cognition, and MLOps the ultimate tool.

  • Board Member

    2020

    Bringing imaging to companion diagnostics

  • Board Member

    2019

    Rethinking the delivery of cell and gene therapies

  • Investor

    2014

    Organ preservation and transplantation

  • Board Member

    2016

    Natrox — Global standard in chronic wound healing

  • Board Member

    2020

    CUE1 is a non-invasive, discrete device relieving the symptoms of Parkinson’s.

  • Board Member

    2015

    Protein interference based phenotypic screening technology

  • Board Member

    2016

    Leading medical review platform for secondary care

Relevant Websites